ADAPY Adaptimmune Therapeutics PLC

Fundamentals / CIK 0001621227 / USD

Adaptimmune Therapeutics PLC reported $65.08M in revenue and a net loss of $169.8M for the trailing twelve months ended June 30, 2025 (down 89.3% year over year), with a 273.4% gross margin and a -252.3% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ADAPY in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2015 to 2024), reported in USD.

$192.9M$96.47M$0-$169.8MFY 2015 Revenue: $9.87MFY 2015 Net Income: -$22.06M2015FY 2016 Revenue: $14.20MFY 2016 Net Income: -$71.58M2016FY 2017 Revenue: $37.83MFY 2017 Net Income: -$70.14M2017FY 2018 Revenue: $59.51MFY 2018 Net Income: -$95.51M2018FY 2019 Revenue: $1.12MFY 2019 Net Income: -$137.2M2019FY 2020 Revenue: $3.96MFY 2020 Net Income: -$130.1M2020FY 2021 Revenue: $6.15MFY 2021 Net Income: -$158.1M2021FY 2022 Revenue: $27.15MFY 2022 Net Income: -$165.5M2022FY 2023 Revenue: $60.28MFY 2023 Net Income: -$113.9M2023FY 2024 Revenue: $178.0MFY 2024 Net Income: -$70.81M2024

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Jun 30
Revenue $178.0M $60.28M $27.15M $6.15M $3.96M $1.12M $59.51M $37.83M $14.20M $9.87M
Cost of Revenue $70K -- -- -- -- -- -- -- -- --
Gross Profit $178.0M -- -- -- -- -- -- -- -- --
Research & Development $149.1M $126.5M $127.7M $111.1M $91.57M $97.50M $98.27M $87.39M $63.79M $24.14M
Selling, General & Admin $87.26M $73.51M $63.39M -- -- -- -- -- -- --
Operating Income -$68.76M -$139.7M -$164.0M -$162.2M -$133.4M -$139.8M -$82.36M -$80.66M -$72.80M -$24.64M
EBITDA -$57.53M -$129.9M -$157.9M -$155.7M -$125.8M -$131.8M -$74.56M -$75.24M -$69.51M -$23.91M
Interest Income -- -- -- -- -- $2.77M $2.85M $2.23M $1.11M $504K
Interest Expense $3.35M -- -- -- -- -- -- -- -- --
Income Before Tax -$67.24M -$112.5M -$163.0M -$157.3M -$129.9M -$136.9M -$95.02M -$69.69M -$70.69M -$21.81M
Income Tax Expense $3.58M $1.34M $2.50M $791K $162K $242K $497K $451K $892K $244K
Net Income -$70.81M -$113.9M -$165.5M -$158.1M -$130.1M -$137.2M -$95.51M -$70.14M -$71.58M -$22.06M
Basic EPS -$0.05 -$0.09 -$0.17 -$0.17 -$0.15 -$0.22 -$0.16 -$0.13 -$0.17 -$0.17
Diluted EPS -$0.05 -$0.09 -$0.17 -$0.17 -$0.15 -$0.22 -$0.16 -$0.13 -$0.17 -$0.17
Basic Shares Outstanding 1.51B 1.21B 967.2M 934.8M 854.8M 629.8M 584.3M 527.6M 424.7M 214.7M
Diluted Shares Outstanding 1.51B 1.21B 967.2M 934.8M 854.8M 629.8M 584.3M 527.6M 424.7M 214.7M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Revenue $13.68M $7.29M $3.22M $40.90M $128.2M $5.68M $231K $7.32M
Cost of Revenue $2.50M $879K -- -- -- -- -- --
Gross Profit $11.18M $6.41M -- -- -- -- -- --
Research & Development $22.98M $28.86M $39.10M $34.30M $40.45M $35.21M $33.21M $37.79M
Selling, General & Admin $18.48M $23.28M $27.17M $21.28M $19.08M $19.73M -- $16.16M
Operating Income -$30.29M -$45.73M -$73.52M -$14.68M $68.70M -$49.26M -$49.86M -$46.63M
EBITDA -$27.78M -$43.27M -$70.68M -$11.86M $71.44M -$46.43M -$46.98M -$43.74M
Interest Expense $962K $1.88M -- $1.11M $526K -- -- --
Income Before Tax -$29.73M -$47.01M -$72.52M -$16.79M $70.05M -$47.98M -$48.57M -$44.91M
Income Tax Expense $612K $575K $1.69M $831K $526K $526K -$656K $687K
Net Income -$30.34M -$47.58M -$74.22M -$17.62M $69.52M -$48.50M -$47.92M -$45.60M
Basic EPS -$0.02 -$0.03 -- -$0.01 $0.05 -$0.03 -- -$0.03
Diluted EPS -$0.02 -$0.03 -- -$0.01 $0.04 -$0.03 -- -$0.03
Basic Shares Outstanding 1.58B 1.54B -- 1.53B 1.53B 1.45B -- 1.36B
Diluted Shares Outstanding 1.58B 1.54B -- 1.53B 1.56B 1.45B -- 1.36B

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $91.14M $144.0M $108.0M $149.9M $56.88M $50.41M $68.38M $84.04M $158.8M $194.3M
Short-Term Investments $60.47M $2.95M $96.57M $219.6M $311.3M $39.13M $136.8M $124.2M -- --
Cash & Short-Term Investments $151.6M $146.9M $204.6M $369.6M $368.2M $89.54M $205.1M $208.3M $158.8M $194.3M
Accounts Receivable, Net $1.45M $821K $7.43M $752K $139K -- $192K $206K $1.48M $744K
Inventory $7.32M -- -- -- -- -- -- -- -- --
Other Current Assets $3.17M $2.41M $1.93M $2.08M $444K $1.81M $439K $382K $976K --
Total Current Assets $188.2M $207.6M $255.4M $415.5M $398.2M $120.5M $231.1M $230.2M $198.8M $263.0M
Property, Plant & Equipment, Net $31.31M $50.95M $53.52M $30.49M $27.78M $31.07M $36.12M $40.68M $27.90M $13.22M
Intangible Assets $3.88M $330K $442K $1.00M $1.73M $2.20M $1.47M $1.34M $1.27M $305K
Other Non-Current Assets $629K -- -- -- -- -- -- -- -- --
Total Non-Current Assets $57.79M $75.06M $73.55M $54.09M $52.99M $61.05M $45.64M $50.96M $35.76M $22.77M
Total Assets $246.0M $282.6M $328.9M $469.5M $451.1M $181.5M $276.7M $281.1M $234.5M $285.8M
Accounts Payable $8.69M $8.13M $4.75M $8.11M $6.39M $6.36M $4.08M $8.38M $11.35M $7.88M
Deferred Revenue (Current) $12.30M $28.97M $23.52M $22.20M $2.83M $2.13M -- $38.73M $11.39M $12.49M
Other Current Liabilities $2.02M $51K $2.15M $327K $47K $56K $742K $357K $1.08M $744K
Total Current Liabilities $64.53M $72.79M $64.50M $62.54M $39.07M $34.34M $24.44M $74.31M $40.27M $27.89M
Long-Term Debt $50.24M -- -- -- -- -- -- -- -- --
Deferred Revenue (Non-Current) $95.81M $149.1M $160.9M $177.2M $49.26M -- -- -- $24.96M $22.94M
Other Non-Current Liabilities $4.27M $1.40M $1.30M $673K $644K $598K $5.41M $3.85M $3.14M --
Total Non-Current Liabilities $169.6M $170.3M $182.5M $201.0M $70.84M $23.56M $5.41M $3.85M $28.10M $22.94M
Total Liabilities $234.1M $243.1M $247.0M $263.6M $109.9M $57.91M $29.85M $78.16M $68.37M $50.83M
Total Debt (incl. Leases) $74.21M $25.23M $23.08M $25.47M $23.71M $25.46M $26.00M -- -- --
Common Stock $2.08M $1.86M $1.40M $1.34M $1.32M $943K $939K $854K $683K $682K
Retained Earnings -$1.09B -$1.02B -$909.3M -$743.8M -$585.8M -$455.7M -$318.5M -$231.6M -$161.5M -$89.91M
Accumulated Other Comp. Income -$1.90M -$3.75M -$875K -$11.14M -$10.05M -$7.26M -$9.76M -$21.64M -$14.25M -$8.14M
Total Stockholders' Equity $11.85M $39.51M $81.88M $206.0M $341.2M $123.6M $246.9M $203.0M $166.1M $235.0M
Total Equity $11.85M $39.51M $81.88M $206.0M $341.2M $123.6M $246.9M $203.0M $166.1M $235.0M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Cash & Cash Equivalents $26.06M $41.05M $91.14M $116.7M $211.8M $140.7M $144.0M $90.06M
Short-Term Investments $0 $18.51M $60.47M $69.35M $2.98M $2.98M $2.95M $71.67M
Cash & Short-Term Investments $26.06M $59.56M $151.6M $186.1M $214.8M $143.7M $146.9M $161.7M
Accounts Receivable, Net $9.31M $4.38M $1.45M $12.50M $2.33M $8.40M $821K $789K
Inventory $11.41M $11.76M $7.32M $1.87M -- -- -- --
Other Current Assets $3.52M $3.35M $3.17M $3.38M $3.29M $2.84M $2.41M $1.68M
Total Current Assets $78.11M $103.0M $188.2M $244.2M $253.8M $186.9M $207.6M $219.4M
Property, Plant & Equipment, Net $28.15M $29.72M $31.31M $44.80M $45.87M $48.29M $50.95M $52.57M
Intangible Assets $3.81M $3.81M $3.88M $4.28M $996K $524K $330K $384K
Other Non-Current Assets $94K $377K $629K $968K -- -- -- --
Total Non-Current Assets $52.52M $55.07M $57.79M $73.22M $67.93M $71.11M $75.06M $77.27M
Total Assets $130.6M $158.1M $246.0M $317.4M $321.7M $258.0M $282.6M $296.6M
Accounts Payable $9.42M $5.70M $8.69M $9.07M $7.51M $6.59M $8.13M $13.92M
Deferred Revenue (Current) $10.70M $12.44M $12.30M $18.71M $38.42M $31.52M $28.97M $29.31M
Other Current Liabilities $1.99M $2.65M $2.02M $1.17M $107K $640K $51K $72K
Total Current Liabilities $51.51M $51.07M $64.53M $63.46M $82.07M $66.41M $72.79M $75.15M
Long-Term Debt $25.68M $25.41M $50.24M $49.87M $24.95M -- -- --
Deferred Revenue (Non-Current) $101.4M $95.98M $95.81M $98.73M $99.86M $147.4M $149.1M $111.5M
Other Non-Current Liabilities $4.49M $4.37M $4.27M $4.94M $1.44M $1.42M $1.40M $1.36M
Total Non-Current Liabilities $150.1M $144.4M $169.6M $174.0M $143.4M $167.2M $170.3M $133.4M
Total Liabilities $201.6M $195.5M $234.1M $237.4M $225.4M $233.6M $243.1M $208.5M
Total Debt (incl. Leases) $48.68M $48.71M $74.21M $74.50M $47.35M $23.69M $25.23M $25.60M
Common Stock $2.16M $2.10M $2.08M $2.08M $2.08M $2.08M $1.86M $1.86M
Retained Earnings -$1.17B -$1.14B -$1.09B -$1.02B -$1.00B -$1.07B -$1.02B -$975.3M
Accumulated Other Comp. Income -$10.61M -$4.41M -$1.90M -$5.14M -$3.41M -$2.72M -$3.75M $102K
Total Stockholders' Equity -$70.96M -$37.43M $11.85M $79.99M $96.27M $24.38M $39.51M $88.13M
Total Equity -$70.96M -$37.43M $11.85M $79.99M $96.27M $24.38M $39.51M $88.13M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Jun 30
Net Income -$70.81M -$113.9M -$165.5M -$158.1M -$130.1M -$137.2M -$95.51M -$70.14M -$71.58M -$22.06M
Depreciation & Amortization $11.22M $9.84M $6.08M $6.57M $7.59M $8.01M $7.81M $5.42M $3.29M $735K
Stock-Based Compensation $12.05M $11.77M $18.24M $20.63M $10.41M $11.05M $16.20M $10.80M $8.82M $7.08M
Change in Inventory -$7.36M -- -- -- -- -- -- -- -- --
Operating Cash Flow -$73.21M -$140.9M -$141.8M $10.73M -$53.59M -$112.5M -$104.4M -$54.31M -$48.17M -$29.67M
Capital Expenditure -$886K -$4.68M -$29.50M -$8.57M -$2.34M -$1.59M -$3.91M -$24.64M -$11.51M -$5.08M
Free Cash Flow -$74.09M -$145.6M -$171.3M $2.15M -$55.93M -$114.1M -$108.3M -$78.96M -$59.67M -$34.75M
Purchases of Investments -$100.4M -$75.95M -$48.12M -$139.8M -$381.0M -$27.28M -$150.8M -$153.3M -- --
Investing Cash Flow -$58.95M $176.5M $89.14M $75.80M -$278.9M $94.94M -$17.46M -$126.1M $17.75M -$58.84M
Common Stock Issued $29.17M $624K $12.82M $2.53M $334.4M -- $99.65M $103.2M -- --
Financing Cash Flow $78.75M $880K $12.87M $3.29M $340.1M $366K $102.7M $103.6M $17K $274.9M
Net Change in Cash -$53.81M $37.41M -$42.06M $90.18M $6.58M -$17.57M -$15.82M -$74.50M -$35.98M $177.9M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Net Income -$30.34M -$47.58M -$74.22M -$17.62M $69.52M -$48.50M -$47.92M -$45.60M
Depreciation & Amortization $2.51M $2.47M $2.83M $2.82M $2.74M $2.83M $2.87M $2.89M
Stock-Based Compensation $1.32M $669K $2.84M $3.06M $3.06M $3.10M $3.08M $3.18M
Change in Inventory $385K -$4.43M -- -- -- -- -- --
Operating Cash Flow -$34.78M -$66.59M -$34.20M -$54.45M $47.40M -$31.95M -$14.68M -$45.16M
Capital Expenditure -$75K -$1.20M -$219K -$143K -$422K -$102K -$827K -$289K
Free Cash Flow -$34.85M -$67.80M -$34.42M -$54.59M $46.98M -$32.05M -$15.50M -$45.45M
Purchases of Investments $0 -$16.09M -- -- -- -- -- --
Investing Cash Flow $18.49M $41.15M $8.17M -$66.02M -$743K -$358K $68.20M $57.31M
Common Stock Issued $1.65M $122K $1.0K $0 $10K $29.16M $1.0K $435K
Financing Cash Flow $1.65M -$25.32M $1.0K $25.00M $24.51M $29.23M $74K $596K
Net Change in Cash -$15.23M -$50.20M -$26.22M -$95.25M $71.15M -$3.49M $53.95M $12.87M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Jun 30
Gross Margin 100.0% -- -- -- -- -- -- -- -- --
Operating Margin -38.6% -231.8% -604.0% -2638.6% -3370.5% -12457.2% -138.4% -213.2% -512.7% -249.6%
Net Profit Margin -39.8% -188.9% -609.5% -2571.0% -3286.8% -12225.0% -160.5% -185.4% -504.1% -223.5%
Return on Equity (ROE) -597.6% -288.2% -202.1% -76.8% -38.1% -110.9% -38.7% -34.6% -43.1% -8.5%
Return on Assets (ROA) -28.8% -40.3% -50.3% -33.7% -28.8% -75.6% -34.5% -24.9% -30.5% -7.3%
Current Ratio 2.92x 2.85x 3.96x 6.64x 10.19x 3.51x 9.46x 3.10x 4.94x 11.02x
Quick Ratio 2.80x 2.03x 3.29x 5.92x 9.43x 2.61x 8.40x 2.81x 3.98x 8.56x
Debt to Equity 6.26x 0.64x 0.28x 0.12x 0.07x 0.21x 0.11x -- -- --
Revenue Growth (YoY) +195.3% +122.0% +341.5% +55.4% +252.8% -98.1% +57.3% +166.5% -- +1096.5%
Operating Cash Flow Growth (YoY) -- -- -1421.4% -- -- -- -- -- -- -180.5%
Free Cash Flow Growth (YoY) -- -- -8047.3% -- -- -- -- -- -- -198.0%
5Y Revenue / Share Growth +6501.5% -50.9% -60.9% -80.3% -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30
Operating Margin -252.3% -36.3% -38.6% -25.8% -54.5% -1038.6% -231.8% -164.8%
Net Profit Margin -260.8% -38.9% -39.8% -25.4% -51.3% -890.1% -188.9% -133.9%
Return on Equity (ROE) -- -- -597.6% -55.7% -75.3% -670.4% -288.2% -108.0%
Return on Assets (ROA) -129.9% -44.2% -28.8% -14.0% -22.5% -63.3% -40.3% -32.1%
Current Ratio 1.52x 2.02x 2.92x 3.85x 3.09x 2.81x 2.85x 2.92x
Quick Ratio 1.29x 1.79x 2.80x 3.82x 2.65x 2.29x 2.03x 2.16x
Debt to Equity -- -- 6.26x 0.93x 0.49x 0.97x 0.64x 0.29x
Revenue Growth (YoY) -89.3% +28.3% +1294.8% +458.8% +2399.6% -88.1% -97.9% +4.5%
Operating Income Growth (YoY) -144.1% -- -- -- -- -3074.7% -- --
Net Income Growth (YoY) -143.6% -- -- -- -- -4781.8% -- --
EPS Growth (YoY) -140.0% -- -- -- -- -- -- --
Operating Cash Flow Growth (YoY) -173.4% -- -- -- -- -- -818.7% --
Free Cash Flow Growth (YoY) -174.2% -- -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001621227) · from June 30, 2014 Data through June 30, 2025 · synced Nov 21, 2026, 05:09 UTC · Open in terminal